• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撒哈拉以南非洲地区接受抗逆转录病毒治疗的艾滋病毒感染者中,HIV-1 RNA病毒抑制的生物学和社会预测因素

Biological and Social Predictors of HIV-1 RNA Viral Suppression in ART Treated PWLH in Sub-Saharan Africa.

作者信息

Gandla Sindhuri, Nakka Raja, Khan Ruhul Ali, Bose Eliezer, Ghebremichael Musie

机构信息

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Department of Mathematics, University of Arizona, Tucson, AZ 85721, USA.

出版信息

Trop Med Infect Dis. 2025 Jan 16;10(1):24. doi: 10.3390/tropicalmed10010024.

DOI:10.3390/tropicalmed10010024
PMID:39852675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768424/
Abstract

HIV remains a significant health issue, especially in sub-Saharan Africa. There are 39 million people living with HIV (PLWH) globally. Treatment with ART improves patient outcomes by suppressing the HIV RNA viral load. However, not all patients treated with ART suppress the HIV RNA viral load. This research paper explores the potential predictors of VL suppression in ART-treated PLWH. We used retrospective data from the 4820 ART-treated participants enrolled through population-based surveys conducted in Zambia and Malawi. We applied several machine learning (ML) classifiers and used the top classifiers to identify the predictors of VL suppression. The age of participants ranged from 15 to 64 years, with a majority being females. The predictive performance of the various ML classifiers ranged from 64% to 92%. In our data from both countries, the logistic classifier was among the top classifiers and was as follows: Malawi (AUC = 0.9255) and Zambia (AUC = 0.8095). Thus, logistic regression was used to identify the predictors of viral suppression. Our findings indicated that besides ART treatment status, older age, higher CD4 T-cell count, and longer duration of ART were identified as significant predictors of viral suppression. Though not statistically significant, ART initiation 12 months or more before the survey, urban residence, and wealth index were also associated with VL suppression. Our findings indicate that HIV prevention programs in the region should integrate education on early ART initiation and adherence in PLWH.

摘要

艾滋病毒仍然是一个重大的健康问题,尤其是在撒哈拉以南非洲地区。全球有3900万人感染艾滋病毒(PLWH)。抗逆转录病毒疗法(ART)治疗通过抑制艾滋病毒RNA病毒载量改善患者预后。然而,并非所有接受ART治疗的患者都能抑制艾滋病毒RNA病毒载量。这篇研究论文探讨了接受ART治疗的PLWH中病毒载量抑制的潜在预测因素。我们使用了通过在赞比亚和马拉维进行的基于人群的调查招募的4820名接受ART治疗参与者的回顾性数据。我们应用了几种机器学习(ML)分类器,并使用顶级分类器来确定病毒载量抑制的预测因素。参与者年龄在15岁至64岁之间,大多数为女性。各种ML分类器的预测性能在64%至92%之间。在我们来自两国的数据中,逻辑回归分类器是顶级分类器之一,具体如下:马拉维(AUC = 0.9255)和赞比亚(AUC = 0.8095)。因此,使用逻辑回归来确定病毒抑制的预测因素。我们的研究结果表明,除了ART治疗状态外,年龄较大、CD4 T细胞计数较高以及ART治疗时间较长被确定为病毒抑制的重要预测因素。虽然在统计学上不显著,但在调查前12个月或更长时间开始接受ART治疗、城市居住和财富指数也与病毒载量抑制有关。我们的研究结果表明,该地区的艾滋病毒预防计划应将对PLWH早期开始接受ART治疗和坚持治疗的教育纳入其中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efb/11768424/b2e121724bb5/tropicalmed-10-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efb/11768424/d36ce4efda17/tropicalmed-10-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efb/11768424/b2e121724bb5/tropicalmed-10-00024-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efb/11768424/d36ce4efda17/tropicalmed-10-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9efb/11768424/b2e121724bb5/tropicalmed-10-00024-g002.jpg

相似文献

1
Biological and Social Predictors of HIV-1 RNA Viral Suppression in ART Treated PWLH in Sub-Saharan Africa.撒哈拉以南非洲地区接受抗逆转录病毒治疗的艾滋病毒感染者中,HIV-1 RNA病毒抑制的生物学和社会预测因素
Trop Med Infect Dis. 2025 Jan 16;10(1):24. doi: 10.3390/tropicalmed10010024.
2
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.在斯威士兰、莱索托、马拉维、赞比亚和津巴布韦,接受抗逆转录病毒疗法的艾滋病毒阳性成年人中病毒载量未受抑制的流行情况及其相关因素(2015 年至 2017 年):基于人群的全国代表性调查结果。
J Int AIDS Soc. 2020 Nov;23(11):e25631. doi: 10.1002/jia2.25631.
3
Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.2005 年至 2018 年 CD4 和病毒载量检测趋势:南部非洲艾滋病毒感染者的多队列研究。
J Int AIDS Soc. 2020 Jul;23(7):e25546. doi: 10.1002/jia2.25546.
4
Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.在非洲队列研究中,接受抗逆转录病毒疗法的成年人中,年龄对 CD4 恢复和病毒抑制随时间的影响。
AIDS Res Ther. 2020 Nov 12;17(1):66. doi: 10.1186/s12981-020-00323-x.
5
Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.津巴布韦城市中基于多替拉韦、阿扎那韦或依非韦伦的 ART 的病毒学结局:一项纵向研究。
PLoS One. 2024 Feb 23;19(2):e0293162. doi: 10.1371/journal.pone.0293162. eCollection 2024.
6
Viral suppression among children and their caregivers living with HIV in western Kenya.肯尼亚西部 HIV 感染者儿童及其照顾者的病毒抑制情况。
J Int AIDS Soc. 2019 Apr;22(4):e25272. doi: 10.1002/jia2.25272.
7
Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.塞纳卡塔纳抗逆转录病毒治疗诊所的抗逆转录病毒治疗方案结局:莱索托四年回顾性队列研究。
Pan Afr Med J. 2023 Nov 2;46:74. doi: 10.11604/pamj.2023.46.74.40122. eCollection 2023.
8
Hearing From Men Living With HIV: Experiences With HIV Testing, Treatment, and Viral Load Suppression in Four High-Prevalence Countries in Sub-Saharan Africa.来自感染艾滋病毒男性的声音:撒哈拉以南非洲四个高流行率国家的艾滋病毒检测、治疗及病毒载量抑制经历
Front Public Health. 2022 May 16;10:861431. doi: 10.3389/fpubh.2022.861431. eCollection 2022.
9
Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.在乌干达的一项横断面研究中,对接受抗逆转录病毒治疗的艾滋病毒感染者进行研究,发现吸烟与缺乏艾滋病毒病毒学抑制之间存在关联。
PLoS One. 2024 Mar 20;19(3):e0300508. doi: 10.1371/journal.pone.0300508. eCollection 2024.
10
Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.乌干达美国总统艾滋病紧急救援计划(PEPFAR)诊所中接受一线治疗方案患者的治疗结果评估:RV288分析中病毒学和免疫学反应的预测因素
HIV Med. 2015 Feb;16(2):95-104. doi: 10.1111/hiv.12177. Epub 2014 Aug 15.

引用本文的文献

1
Universal "Test and Treat" for HIV Had Little Effect on Outcomes, but Missed Clinic Visits Threaten Success of Botswana's National Antiretroviral Treatment Program.针对艾滋病病毒的普遍“检测与治疗”对治疗结果影响甚微,但错过门诊就诊威胁着博茨瓦纳国家抗逆转录病毒治疗项目的成功。
AIDS Patient Care STDS. 2025 Jun;39(6):215-223. doi: 10.1089/apc.2025.0042. Epub 2025 May 20.

本文引用的文献

1
The viral load monitoring cascade in HIV treatment programmes in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区艾滋病毒治疗规划中的病毒载量监测级联:系统评价。
BMC Public Health. 2024 Sep 27;24(1):2603. doi: 10.1186/s12889-024-20013-x.
2
Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study.在戈达大学综合专科医院接受抗逆转录病毒治疗的 HIV 阳性成年人中病毒载量抑制的预测因素:回顾性队列研究。
Sci Rep. 2024 Feb 8;14(1):3258. doi: 10.1038/s41598-024-53569-0.
3
Dolutegravir based therapy showed CD4 T cell count recovery and viral load suppression among ART naïve people living with HIV AIDS: a pilot evaluation.
多替拉韦为基础的治疗方案在 HIV 艾滋病初治患者中显示出了 CD4 细胞计数恢复和病毒载量抑制的效果:一项初步评估。
Sci Rep. 2024 Feb 8;14(1):3297. doi: 10.1038/s41598-024-53282-y.
4
Barriers and facilitators for interventions to improve ART adherence in Sub-Saharan African countries: A systematic review and meta-analysis.改善撒哈拉以南非洲国家抗逆转录病毒治疗(ART)依从性的干预措施的障碍和促进因素:系统评价和荟萃分析。
PLoS One. 2023 Nov 30;18(11):e0295046. doi: 10.1371/journal.pone.0295046. eCollection 2023.
5
Barriers and facilitators to ART adherence among ART non-adherence people living with HIV in Cameroon: A qualitative phenomenological study.喀麦隆抗逆转录病毒治疗不依从的艾滋病毒感染者坚持抗逆转录病毒治疗的障碍和促进因素:一项定性现象学研究。
PLoS One. 2023 Sep 12;18(9):e0291487. doi: 10.1371/journal.pone.0291487. eCollection 2023.
6
The epidemiology of HIV population viral load in twelve sub-Saharan African countries.HIV 人群病毒载量在撒哈拉以南非洲十二个国家的流行情况。
PLoS One. 2023 Jun 26;18(6):e0275560. doi: 10.1371/journal.pone.0275560. eCollection 2023.
7
Progress in scale up of HIV viral load testing in select sub-Saharan African countries 2016-2018.2016-2018 年撒哈拉以南非洲部分国家扩大艾滋病毒病毒载量检测的进展。
PLoS One. 2023 Mar 15;18(3):e0282652. doi: 10.1371/journal.pone.0282652. eCollection 2023.
8
Barriers and facilitators of antiretroviral therapy (ART) adherence habit formation in Sub-Saharan Africa: Evidence from a qualitative study in Kampala, Uganda.撒哈拉以南非洲地区抗逆转录病毒疗法(ART)依从性习惯形成的障碍和促进因素:来自乌干达坎帕拉的定性研究证据。
Soc Sci Med. 2023 Jan;317:115567. doi: 10.1016/j.socscimed.2022.115567. Epub 2022 Nov 21.
9
Socioeconomic inequalities in the 90-90-90 target, among people living with HIV in 12 sub-Saharan African countries - Implications for achieving the 95-95-95 target - Analysis of population-based surveys.撒哈拉以南非洲12个国家艾滋病毒感染者中90-90-90目标的社会经济不平等——对实现95-95-95目标的影响——基于人群调查的分析
EClinicalMedicine. 2022 Sep 17;53:101652. doi: 10.1016/j.eclinm.2022.101652. eCollection 2022 Nov.
10
Achieving the 95 95 95 targets for all: A pathway to ending AIDS.实现所有人的 95-95-95 目标:终结艾滋病的途径。
PLoS One. 2022 Aug 4;17(8):e0272405. doi: 10.1371/journal.pone.0272405. eCollection 2022.